Home » Topics » BioWorld Science

BioWorld Science
RSS

Alkahest initiates phase II study of GRF-6019 in Alzheimer's disease

April 25, 2018

FDA approves expanded indication for Trelegy Ellipta in COPD

April 25, 2018

Novel CDK4/6 inhibitor TQB-3616 presented for cancer therapy

April 25, 2018

FDA grants fast track designation to EC-18 for chemoradiation-induced oral mucositis

April 25, 2018

Synthetic Biologics withdraws breakthrough therapy designation for ribaxamase

April 25, 2018

Theratechnologies to seek European approval for Trogarzo based on available data

April 25, 2018

FDA gives orphan drug designation to AMP-L2.7.D7 for congenital erythropoietic porphyria

April 25, 2018

New 5'-nucleotidase inhibitors identified at Arcus Biosciences

April 25, 2018

Bristol-Myers Squibb presents new TYK2 inhibitors

April 25, 2018

Novel farnesoid X receptor agonists described by Enanta Pharmaceuticals

April 25, 2018

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...